{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:42:45Z","timestamp":1784054565447,"version":"3.55.0"},"reference-count":78,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["P68125"],"award-info":[{"award-number":["P68125"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health","award":["HL68024"],"award-info":[{"award-number":["HL68024"]}]},{"name":"National Institutes of Health","award":["HL117247"],"award-info":[{"award-number":["HL117247"]}]},{"name":"National Institutes of Health","award":["HL138992"],"award-info":[{"award-number":["HL138992"]}]},{"name":"American Heart Association","award":["0540054N"],"award-info":[{"award-number":["0540054N"]}]},{"name":"American Heart Association","award":["7770000"],"award-info":[{"award-number":["7770000"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0218934","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T13:41:34Z","timestamp":1561556494000},"page":"e0218934","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel"],"prefix":"10.1371","volume":"14","author":[{"given":"Hasseri","family":"Halim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decha","family":"Pinkaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preedakorn","family":"Chunhacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patuma","family":"Sinthujaroen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perumal","family":"Thiagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6763-8055","authenticated-orcid":true,"given":"Ken","family":"Fujise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,6,26]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11886-017-0810-9","article-title":"Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease","volume":"19","author":"S Ariotti","year":"2017","journal-title":"Curr Cardiol Rep"},{"issue":"16","key":"ref2","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/eurheartj\/ehp296","article-title":"P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use","volume":"30","author":"L. Wallentin","year":"2009","journal-title":"Eur Heart J"},{"issue":"8 Suppl","key":"ref3","doi-asserted-by":"crossref","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the vulnerable plaque","volume":"47","author":"R Virmani","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"L Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"18","key":"ref5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jacc.2010.03.100","article-title":"Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy","volume":"56","author":"RF Storey","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2014.156","article-title":"Novel antiplatelet agents in acute coronary syndrome","volume":"12","author":"F Franchi","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"20","key":"ref7","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"SD Wiviott","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease","volume":"376","author":"WR Hiatt","year":"2017","journal-title":"N Engl J Med"},{"issue":"19","key":"ref9","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"MP Bonaca","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00380-015-0696-7","article-title":"Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo","volume":"31","author":"C Heim","year":"2016","journal-title":"Heart Vessels"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"e0141464","DOI":"10.1371\/journal.pone.0141464","article-title":"A Potential Mechanism of High-Dose Ticagrelor in Modulating Platelet Activity and Atherosclerosis Mediated by Thymic Stromal Lymphopoietin Receptor","volume":"10","author":"Y Mao","year":"2015","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.2147\/DDDT.S105718","article-title":"Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis","volume":"10","author":"MR Preusch","year":"2016","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"ref13","first-page":"49","article-title":"Ticagrelor: Effects Beyond the P2Y12 Receptor","volume":"6","author":"W Sumaya","year":"2017","journal-title":"Interv Cardiol Clin"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1074248413511693","article-title":"Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1","volume":"19","author":"D Armstrong","year":"2014","journal-title":"Journal of cardiovascular pharmacology and therapeutics"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jacc.2013.09.067","article-title":"Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome","volume":"63","author":"L Bonello","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"ref16","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.jacc.2014.03.031","article-title":"Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance","volume":"63","author":"M Cattaneo","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1161\/ATVBAHA.115.306528","article-title":"Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model","volume":"35","author":"MR Thomas","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000322789","article-title":"Mortality benefit in PLATO cannot be explained by antiplatelet properties of ticagrelor","volume":"117","author":"VL Serebruany","year":"2010","journal-title":"Cardiology"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/bph.13429","article-title":"Effects of P2Y12 receptor antagonists beyond platelet inhibition\u2014comparison of ticagrelor with thienopyridines","volume":"173","author":"S Nylander","year":"2016","journal-title":"Br J Pharmacol"},{"issue":"23","key":"ref20","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"L Mauri","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0049-3848(90)90173-A","article-title":"A new platelet function test","volume":"58","author":"WL Ryan","year":"1990","journal-title":"Thromb Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-1-62703-339-8_17","article-title":"Light transmission aggregometry","volume":"992","author":"JP Frontroth","year":"2013","journal-title":"Methods Mol Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.plabm.2018.02.002","article-title":"Assessment of a flow cytometry technique for studying signaling pathways in platelets: Monitoring of VASP phosphorylation in clinical samples","volume":"11","author":"N Mallouk","year":"2018","journal-title":"Practical Laboratory Medicine"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1055\/s-0037-1614344","article-title":"Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets\u2014definition and detection of ticlopidine\/clopidogrel effects","volume":"82","author":"UR Schwarz","year":"1999","journal-title":"Thromb Haemost"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5493\/wjem.v2.i2.30","article-title":"Standardizing a simpler, more sensitive and accurate tail bleeding assay in mice","volume":"2","author":"Y Liu","year":"2012","journal-title":"World J Exp Med"},{"key":"ref26","article-title":"Fortilin Reduces Apoptosis in Macrophages and Promotes Atherosclerosis","author":"D Pinkaew","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"H451","DOI":"10.1152\/ajpheart.00669.2011","article-title":"Morelloflavone, a biflavonoid inhibitor of migration-related kinases, ameliorates atherosclerosis in mice","volume":"302","author":"D Pinkaew","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/21556660.2014.946604","article-title":"Absolute bioavailability and regional absorption of ticagrelor in healthy volunteers","volume":"3","author":"R Teng","year":"2014","journal-title":"J Drug Assess"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1124\/dmd.110.032250","article-title":"Absorption, distribution, metabolism, and excretion of ticagrelor in healthy subjects","volume":"38","author":"R Teng","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nm0898-934","article-title":"A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet","volume":"4","author":"L Powell-Braxton","year":"1998","journal-title":"Nat Med"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9150(03)00133-3","article-title":"Hepatic gene expression profiling reveals perturbed calcium signaling in a mouse model lacking both LDL receptor and Apobec1 genes","volume":"169","author":"R Dutta","year":"2003","journal-title":"Atherosclerosis"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41598-017-00977-0","article-title":"Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis","volume":"7","author":"CL Liu","year":"2017","journal-title":"Scientific reports"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2011-09-376202","article-title":"ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice","volume":"119","author":"C Gandhi","year":"2012","journal-title":"Blood"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1083\/jcb.135.6.1441","article-title":"Lamin proteolysis facilitates nuclear events during apoptosis","volume":"135","author":"L Rao","year":"1996","journal-title":"J Cell Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"18701","DOI":"10.1038\/srep18701","article-title":"Fortilin potentiates the peroxidase activity of Peroxiredoxin-1 and protects against alcohol-induced liver damage in mice","volume":"6","author":"A Chattopadhyay","year":"2016","journal-title":"Scientific reports"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"C Trapnell","year":"2010","journal-title":"Nature biotechnology"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"C Trapnell","year":"2012","journal-title":"Nature protocols"},{"issue":"37","key":"ref38","doi-asserted-by":"crossref","first-page":"32575","DOI":"10.1074\/jbc.M110.217836","article-title":"Physical and functional antagonism between tumor suppressor protein p53 and fortilin, an anti-apoptotic protein","volume":"286","author":"Y Chen","year":"2011","journal-title":"J Biol Chem"},{"issue":"22","key":"ref39","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1161\/01.CIR.0000070954.00271.13","article-title":"Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study","volume":"107","author":"B Mackness","year":"2003","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"12570","DOI":"10.1038\/ncomms12570","article-title":"Rewiring of jasmonate and phytochrome B signalling uncouples plant growth-defense tradeoffs","volume":"7","author":"ML Campos","year":"2016","journal-title":"Nature communications"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"42545","DOI":"10.1038\/srep42545","article-title":"GARP2 accelerates retinal degeneration in rod cGMP-gated cation channel beta-subunit knockout mice","volume":"7","author":"ML DeRamus","year":"2017","journal-title":"Scientific reports"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/978-1-4939-2694-7_47","article-title":"Protein detection by Simple Western analysis","volume":"1312","author":"VM Harris","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1038\/npp.2015.99","article-title":"Failure to Recognize Novelty after Extended Methamphetamine Self-Administration Results from Loss of Long-Term Depression in the Perirhinal Cortex","volume":"40","author":"MD Scofield","year":"2015","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2125.2010.03669.x","article-title":"Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers","volume":"70","author":"K Butler","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"ref45","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1177\/0091270010379409","article-title":"Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with mild hepatic impairment","volume":"51","author":"K Butler","year":"2011","journal-title":"Journal of clinical pharmacology"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1177\/0091270011415526","article-title":"Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with severe renal impairment","volume":"52","author":"K Butler","year":"2012","journal-title":"Journal of clinical pharmacology"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/phar.1477","article-title":"Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety","volume":"34","author":"PP Dobesh","year":"2014","journal-title":"Pharmacotherapy"},{"key":"ref48","article-title":"Adenosine and Ticagrelor Plasma Levels in Patients With and Without Ticagrelor-Related Dyspnea","author":"L Ortega-Paz","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.ATV.0000019729.39500.2F","article-title":"Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression","volume":"22","author":"E Lutgens","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/ATVBAHA.116.307580","article-title":"Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice","volume":"36","author":"VR Babaev","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"ref51","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/01.ATV.19.10.2364","article-title":"Interleukin-6 exacerbates early atherosclerosis in mice","volume":"19","author":"SA Huber","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2018.02.005","article-title":"Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Tromso Study","volume":"271","author":"A Eltoft","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000335886","article-title":"Macrophage inflammatory protein-1beta and fibrinogen are synergistic predictive markers of prognosis of intermediate coronary artery lesions","volume":"121","author":"F Xu","year":"2012","journal-title":"Cardiology"},{"issue":"8","key":"ref54","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI6993","article-title":"Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells","volume":"104","author":"F Mach","year":"1999","journal-title":"J Clin Invest"},{"issue":"19","key":"ref55","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.105.605121","article-title":"Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells","volume":"113","author":"EA Heller","year":"2006","journal-title":"Circulation"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"936109","DOI":"10.4061\/2011\/936109","article-title":"Atherosclerotic Plaque Stability Is Affected by the Chemokine CXCL10 in Both Mice and Humans","volume":"2011","author":"D Segers","year":"2011","journal-title":"Int J Inflam"},{"issue":"2\u20133","key":"ref57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0021-9150(91)90066-C","article-title":"Tumor necrosis factor-alpha in human arterial wall with atherosclerosis","volume":"89","author":"HG Rus","year":"1991","journal-title":"Atherosclerosis"},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/path.2305","article-title":"Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha","volume":"214","author":"M Canault","year":"2008","journal-title":"The Journal of pathology"},{"issue":"11","key":"ref59","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.ATV.0000143933.20616.1b","article-title":"Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice","volume":"24","author":"L Branen","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"ref60","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1517\/14728222.2013.790367","article-title":"Targeting paraoxonase-1 in atherosclerosis","volume":"17","author":"M Mackness","year":"2013","journal-title":"Expert opinion on therapeutic targets"},{"issue":"34","key":"ref61","doi-asserted-by":"crossref","first-page":"29501","DOI":"10.1074\/jbc.M111.263509","article-title":"Early growth response 1 (Egr1) regulates cholesterol biosynthetic gene expression","volume":"286","author":"NG Gokey","year":"2011","journal-title":"J Biol Chem"},{"issue":"7","key":"ref62","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.ATV.17.7.1233","article-title":"Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis","volume":"17","author":"B Mackness","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"ref63","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2362.2010.02411.x","article-title":"Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques","volume":"41","author":"J Marsillach","year":"2011","journal-title":"Eur J Clin Invest"},{"issue":"6690","key":"ref64","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"DM Shih","year":"1998","journal-title":"Nature"},{"issue":"23","key":"ref65","doi-asserted-by":"crossref","first-page":"17527","DOI":"10.1074\/jbc.M910376199","article-title":"Combined serum paraoxonase knockout\/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis","volume":"275","author":"DM Shih","year":"2000","journal-title":"J Biol Chem"},{"issue":"10","key":"ref66","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.4049\/jimmunol.173.10.6366","article-title":"Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice","volume":"173","author":"DJ Grainger","year":"2004","journal-title":"J Immunol"},{"issue":"5","key":"ref67","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0002-9149(90)90291-8","article-title":"Detection and localization of tumor necrosis factor in human atheroma","volume":"65","author":"P Barath","year":"1990","journal-title":"Am J Cardiol"},{"issue":"3","key":"ref68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0049-3848(89)90098-4","article-title":"Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells","volume":"53","author":"EM Conway","year":"1989","journal-title":"Thromb Res"},{"issue":"6","key":"ref69","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.CIR.94.6.1226","article-title":"Identification of active tissue factor in human coronary atheroma","volume":"94","author":"JD Marmur","year":"1996","journal-title":"Circulation"},{"issue":"25","key":"ref70","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1161\/hc2501.092492","article-title":"Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice","volume":"103","author":"RJ Westrick","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"ref71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/cvr\/cvw233","article-title":"Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression","volume":"113","author":"MF Reiner","year":"2017","journal-title":"Cardiovasc Res"},{"issue":"6","key":"ref72","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10557-013-6484-7","article-title":"Pro-inflammatory role of platelets in hypertension-mediated end-organ damage: Editorial to: "Inhibition of Platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis" by L.-X. Jia","volume":"27","author":"XJ Du","year":"2013","journal-title":"Cardiovascular drugs and therapy \/ sponsored by the International Society of Cardiovascular Pharmacotherapy"},{"issue":"6","key":"ref73","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10557-013-6471-z","article-title":"Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis","volume":"27","author":"LX Jia","year":"2013","journal-title":"Cardiovascular drugs and therapy \/ sponsored by the International Society of Cardiovascular Pharmacotherapy"},{"issue":"2","key":"ref74","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0008-6363(98)00276-4","article-title":"Atherosclerotic plaque rupture\u2014pathologic basis of plaque stability and instability","volume":"41","author":"AC van der Wal","year":"1999","journal-title":"Cardiovasc Res"},{"issue":"12","key":"ref75","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/cdd.2013.138","article-title":"Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance","volume":"20","author":"S Dalleau","year":"2013","journal-title":"Cell Death Differ"},{"issue":"9","key":"ref76","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1517\/13543780903176415","article-title":"Platelet P2Y12 receptor inhibition by thienopyridines: status and future","volume":"18","author":"I Porto","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2013.06.007","article-title":"Hepatocellular toxicity of clopidogrel: mechanisms and risk factors","volume":"65","author":"A Zahno","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"ref78","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/01480545.2015.1122606","article-title":"The mechanism and risk factors of clopidogrel-induced liver injury","volume":"39","author":"Y Zhai","year":"2016","journal-title":"Drug Chem Toxicol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0218934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:32:58Z","timestamp":1588962778000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0218934"}},"subtitle":[],"editor":[{"given":"Michael","family":"Bader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,26]]},"references-count":78,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0218934","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,26]]}}}